62 related articles for article (PubMed ID: 10625203)
1. Efficacy of antithrombin replacement therapy in severe early-onset preeclampsia.
Nakabayashi M; Asami M; Nakatani A
Semin Thromb Hemost; 1999; 25(5):463-6. PubMed ID: 10625203
[TBL] [Abstract][Full Text] [Related]
2. Treatment of severe preeclampsia with antithrombin concentrate: results of a prospective feasibility study.
Kobayashi T; Terao T; Ikenoue T; Sameshima H; Nakabayashi M; Kajiwara Y; Maki M;
Semin Thromb Hemost; 2003 Dec; 29(6):645-52. PubMed ID: 14719181
[TBL] [Abstract][Full Text] [Related]
3. Antithrombin therapy for severe preeclampsia: results of a double-blind, randomized, placebo-controlled trial. BI51.017 Study Group.
Maki M; Kobayashi T; Terao T; Ikenoue T; Satoh K; Nakabayashi M; Sagara Y; Kajiwara Y; Urata M
Thromb Haemost; 2000 Oct; 84(4):583-90. PubMed ID: 11057854
[TBL] [Abstract][Full Text] [Related]
4. Antithrombin improves fetal condition in women with severe pre-eclampsia before 32 weeks of gestation; a randomized, double-blind, placebo-controlled trial.
Sameshima H; Kodama Y; Ikenoue T; Kajiwara Y
J Obstet Gynaecol Res; 2008 Feb; 34(1):34-9. PubMed ID: 18226126
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of maternal and umbilical serum TNFalpha levels in preeclamptic pregnancies in the intrauterine normal and growth-restricted fetus.
Laskowska M; Leszczyńska-Gorzelak B; Laskowska K; Oleszczuk J
J Matern Fetal Neonatal Med; 2006 Jun; 19(6):347-51. PubMed ID: 16801311
[TBL] [Abstract][Full Text] [Related]
6. [Anticoagulant therapy in obstetrical disorders].
Murata M; Hayakawa M; Goto K; Isobe K; Matuura T; Hirano H; Higuchi M; Maki M
Rinsho Ketsueki; 1990 Jun; 31(6):763-8. PubMed ID: 2170703
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of the maternal and umbilical interleukin-8 levels in normal pregnancies and in pregnancies complicated by preeclampsia with intrauterine normal growth and intrauterine growth retardation.
Laskowska M; Laskowska K; Leszczyńska-Gorzelak B; Oleszczuk J
J Matern Fetal Neonatal Med; 2007 Jul; 20(7):527-32. PubMed ID: 17674266
[TBL] [Abstract][Full Text] [Related]
8. Association of hypercytokinemia in the development of severe preeclampsia in a case of hemophagocytic syndrome.
Nakabayashi M; Adachi T; Izuchi S; Sugisaki A
Semin Thromb Hemost; 1999; 25(5):467-71. PubMed ID: 10625204
[TBL] [Abstract][Full Text] [Related]
9. The analysis of the correlation between extracellular fetal DNA concentration in maternal circulation and severity of preeclampsia.
Engel K; Płonka T; Bilar M; Czajkowska E; Orzińska E; Brojer E; Ronin-Walknowska E
Ann Acad Med Stetin; 2007; 53(3):20-5. PubMed ID: 18595481
[TBL] [Abstract][Full Text] [Related]
10. Increase in serum concentrations of inhibin in early onset pre-eclampsia with intrauterine growth restriction.
Itoh Y; Suzuki Y; Yamamoto T; Kojima K; Murakami I; Suzumori N
J Obstet Gynaecol Res; 2006 Feb; 32(1):80-5. PubMed ID: 16445530
[TBL] [Abstract][Full Text] [Related]
11. Divergent trophoblast invasion and apoptosis in placental bed spiral arteries from pregnancies complicated by maternal anemia and early-onset preeclampsia/intrauterine growth restriction.
Kadyrov M; Kingdom JC; Huppertz B
Am J Obstet Gynecol; 2006 Feb; 194(2):557-63. PubMed ID: 16458661
[TBL] [Abstract][Full Text] [Related]
12. Preeclampsia and fetal growth.
Odegård RA; Vatten LJ; Nilsen ST; Salvesen KA; Austgulen R
Obstet Gynecol; 2000 Dec; 96(6):950-5. PubMed ID: 11084184
[TBL] [Abstract][Full Text] [Related]
13. TNF-receptor levels in preeclampsia--results of a longitudinal study in high-risk women.
Schipper EJ; Bolte AC; Schalkwijk CG; Van Geijn HP; Dekker GA
J Matern Fetal Neonatal Med; 2005 Nov; 18(5):283-7. PubMed ID: 16390786
[TBL] [Abstract][Full Text] [Related]
14. Maternal cardiac autonomic function and fetal heart rate in preeclamptic compared to normotensive pregnancies.
Swansburg ML; Brown CA; Hains SM; Smith GN; Kisilevsky BS
Can J Cardiovasc Nurs; 2005; 15(3):42-52. PubMed ID: 16295797
[TBL] [Abstract][Full Text] [Related]
15. Association between tumor necrosis factor (TNF)-alpha G-308A gene polymorphism and preeclampsia complicated by severe fetal growth restriction.
Molvarec A; Jermendy A; Nagy B; Kovács M; Várkonyi T; Hupuczi P; Prohászka Z; Rigó J
Clin Chim Acta; 2008 Jun; 392(1-2):52-7. PubMed ID: 18396154
[TBL] [Abstract][Full Text] [Related]
16. Expectant management of severe preterm preeclampsia: is intrauterine growth restriction an indication for immediate delivery?
Chammas MF; Nguyen TM; Li MA; Nuwayhid BS; Castro LC
Am J Obstet Gynecol; 2000 Oct; 183(4):853-8. PubMed ID: 11035325
[TBL] [Abstract][Full Text] [Related]
17. Hypothesis: selective phosphodiesterase-5 inhibition improves outcome in preeclampsia.
Downing JW; Ramasubramanian R; Johnson RF; Minzter BH; Paschall RL; Sundell HW; Engelhardt B; Lewis R
Med Hypotheses; 2004; 63(6):1057-64. PubMed ID: 15504576
[TBL] [Abstract][Full Text] [Related]
18. Second-trimester plasma homocysteine levels and pregnancy-induced hypertension, preeclampsia, and intrauterine growth restriction.
Hogg BB; Tamura T; Johnston KE; Dubard MB; Goldenberg RL
Am J Obstet Gynecol; 2000 Oct; 183(4):805-9. PubMed ID: 11035317
[TBL] [Abstract][Full Text] [Related]
19. sCD40 ligand determined in maternal and umbilical cord blood in pregnancies complicated by pre-eclampsia with and without intrauterine growth retardation.
Laskowska M; Laskowska K; Leszczyńska-Gorzelak B; Oleszczuk J
Gynecol Obstet Invest; 2007; 64(1):8-13. PubMed ID: 17199090
[TBL] [Abstract][Full Text] [Related]
20. [Thrombophilia, preeclampsia and other pregnancy complications].
Vucić N; Frleta M; Petrović D; Ostojić V
Acta Med Croatica; 2009 Oct; 63(4):297-305. PubMed ID: 20034330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
